Chia Seeds Consumption in Hypertriglyceridemia

Status Completed

Clinical Trial Summary

Lifestyle changes including diet therapy and weight loss can improve hypertriglyceridemia (HTG) . Furthermore, increasing omega-3 fatty acids intake has therapeutic effects on HTG. Alpha-linolenic acid is the precursor of long-chain omega-3 fatty acid and it is abundant in sources such as chia seeds and flax seeds. Considering the high fiber and omega-3 content of chia seeds and the existing mechanisms for improving lipid profile through fiber and omega-3, animal studies have shown the positive role of chia seed consumption on lipid profile, glycemic and lipid factors, and inflammation. However, in human studies, conflicting results have been obtained and some studies have shown beneficial effects on blood lipid, glycemic, and inflammatory factors, but in some studies, no effect has been observed. The objective of this study is to determine the effects of chia seed consumption on lipids, glycemic and inflammatory factors in people with HTG.

Clinical Trial Description

This study is an unblinded randomized controlled clinical trial. The study will be conducted on people with mild to moderate hypertriglyceridemia whose fasting blood triglyceride levels were between 150-499 mg/dL in the previous two tests. Participants who meet the following criteria will not be included in the study: Being treated with fibrate medications, end-stage kidney disease, acquired immunodeficiency syndrome patients, cancer patients undergoing chemotherapy or radiotherapy, patients with liver cirrhosis, being treated glucocorticoids, continuous use of omega-3 supplements or in the past month, and pregnancy or lactation. Patients will be randomly assigned to one of three study groups. The duration of the study will be 8 week. The groups are: the control group, which is given a placebo pearls containing sunflower oil. the omega-3 oil group will be given omega-3 pearls, and the chia seed group that will consume chia seeds. In addition, the participants of all three groups are subjected to a low-calorie diet. At the beginning and end of the study, the measurements include body weight, blood pressure, blood concentration of lipids, lipoproteins and inflammatory factors. ;

Study Design

Related Conditions & MeSH terms

Hypertriglyceridemia

Clinical Trial Details

NCT number	NCT06020950
Study type	Interventional
Source	Shahid Beheshti University
Contact
Status	Completed
Phase	N/A
Start date	September 18, 2023
Completion date	March 16, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03929198` - Translation of Pritikin Program to the Community	N/A
Completed	`NCT02250105` - Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia	Phase 2
Completed	`NCT02859129` - Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)	Phase 1
Completed	`NCT01455844` - TRIal For Efficacy of Capre on hyperTriglyceridemiA	Phase 2
Completed	`NCT01437930` - Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemic Patients	N/A
Completed	`NCT01010399` - Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects	Phase 4
Completed	`NCT00959842` - Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia	Phase 1/Phase 2
Completed	`NCT00519714` - A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)	Phase 2/Phase 3
Recruiting	`NCT00186537` - Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.	N/A
Completed	`NCT00246402` - Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV	N/A
Completed	`NCT02354976` - A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.	Phase 2
Completed	`NCT04966494` - Impact of Beans and Oats Snack Bar on Hypertriglyceridemic Women	N/A
Completed	`NCT04630366` - A Phase 1, First Time in Humans Study of NST-1024	Phase 1
Completed	`NCT04650152` - Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
Completed	`NCT03693131` - Efficacy of MND-2119 in Participants With Hypertriglyceridemia	Phase 3
Completed	`NCT02868177` - Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes	Phase 2/Phase 3
Completed	`NCT04756180` - An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.	Phase 3
Completed	`NCT01968720` - Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia	Phase 2
Completed	`NCT01462877` - A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic	Phase 4
Completed	`NCT01211847` - Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia	Phase 2